ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/05/02 | 4,309 | 4,355 | 4,283 | 4,301 | -23 | -0.5% | 202,800 |
2025/05/01 | 4,298 | 4,350 | 4,269 | 4,324 | +36 | +0.8% | 331,100 |
2025/04/30 | 4,318 | 4,332 | 4,279 | 4,288 | -28 | -0.6% | 204,000 |
2025/04/28 | 4,293 | 4,368 | 4,293 | 4,316 | +50 | +1.2% | 202,000 |
2025/04/25 | 4,291 | 4,328 | 4,255 | 4,266 | -24 | -0.6% | 305,900 |
2025/04/24 | 4,404 | 4,413 | 4,276 | 4,290 | -114 | -2.6% | 225,200 |
2025/04/23 | 4,397 | 4,433 | 4,387 | 4,404 | +7 | +0.2% | 247,700 |
2025/04/22 | 4,383 | 4,414 | 4,371 | 4,397 | +8 | +0.2% | 144,000 |
2025/04/21 | 4,400 | 4,450 | 4,369 | 4,389 | -11 | -0.3% | 138,500 |
2025/04/18 | 4,343 | 4,410 | 4,315 | 4,400 | +119 | +2.8% | 224,400 |
2025/04/17 | 4,292 | 4,296 | 4,249 | 4,281 | -25 | -0.6% | 142,300 |
2025/04/16 | 4,249 | 4,310 | 4,245 | 4,306 | +65 | +1.5% | 153,600 |
2025/04/15 | 4,221 | 4,257 | 4,214 | 4,241 | +50 | +1.2% | 170,200 |
2025/04/14 | 4,100 | 4,204 | 4,100 | 4,191 | +122 | +3% | 242,000 |
2025/04/11 | 4,079 | 4,081 | 3,983 | 4,069 | -67 | -1.6% | 211,800 |
2025/04/10 | 4,110 | 4,136 | 4,060 | 4,136 | +149 | +3.7% | 320,700 |
2025/04/09 | 4,000 | 4,014 | 3,935 | 3,987 | -70 | -1.7% | 299,300 |
2025/04/08 | 4,033 | 4,090 | 4,003 | 4,057 | +94 | +2.4% | 320,700 |
2025/04/07 | 4,061 | 4,085 | 3,938 | 3,963 | -238 | -5.7% | 476,000 |
2025/04/04 | 4,180 | 4,225 | 4,143 | 4,201 | +6 | +0.1% | 332,800 |
2025/04/03 | 4,170 | 4,239 | 4,141 | 4,195 | -11 | -0.3% | 314,700 |
2025/04/02 | 4,311 | 4,331 | 4,206 | 4,206 | -136 | -3.1% | 260,300 |
2025/04/01 | 4,355 | 4,389 | 4,334 | 4,342 | +27 | +0.6% | 174,600 |
2025/03/31 | 4,373 | 4,380 | 4,314 | 4,315 | -69 | -1.6% | 235,500 |
2025/03/28 | 4,377 | 4,398 | 4,342 | 4,384 | -96 | -2.1% | 207,700 |
2025/03/27 | 4,420 | 4,480 | 4,396 | 4,480 | +39 | +0.9% | 289,500 |
2025/03/26 | 4,393 | 4,465 | 4,383 | 4,441 | +71 | +1.6% | 366,900 |
2025/03/25 | 4,385 | 4,393 | 4,335 | 4,370 | -50 | -1.1% | 277,100 |
2025/03/24 | 4,455 | 4,455 | 4,395 | 4,420 | -6 | -0.1% | 233,000 |
2025/03/21 | 4,390 | 4,445 | 4,374 | 4,426 | +34 | +0.8% | 431,000 |
2025/03/19 | 4,450 | 4,490 | 4,390 | 4,392 | -83 | -1.9% | 404,800 |
2025/03/18 | 4,492 | 4,509 | 4,467 | 4,475 | +16 | +0.4% | 276,400 |
2025/03/17 | 4,460 | 4,478 | 4,412 | 4,459 | -37 | -0.8% | 300,400 |
2025/03/14 | 4,409 | 4,515 | 4,375 | 4,496 | +68 | +1.5% | 380,500 |
2025/03/13 | 4,365 | 4,428 | 4,365 | 4,428 | +8 | +0.2% | 241,700 |
2025/03/12 | 4,246 | 4,433 | 4,243 | 4,420 | +174 | +4.1% | 495,000 |
2025/03/11 | 4,236 | 4,300 | 4,161 | 4,246 | -10 | -0.2% | 765,800 |
2025/03/10 | 4,214 | 4,349 | 4,200 | 4,256 | +44 | +1% | 2,102,900 |
2025/03/07 | 4,192 | 4,248 | 4,170 | 4,212 | -2 | ±0% | 543,500 |
2025/03/06 | 4,303 | 4,313 | 4,206 | 4,214 | -84 | -2% | 488,800 |
2025/03/05 | 4,261 | 4,344 | 4,250 | 4,298 | +28 | +0.7% | 590,700 |
2025/03/04 | 4,229 | 4,298 | 4,221 | 4,270 | -29 | -0.7% | 1,362,600 |
2025/03/03 | 4,310 | 4,347 | 4,267 | 4,299 | +6 | +0.1% | 1,013,400 |
2025/02/28 | 4,235 | 4,324 | 4,221 | 4,293 | +56 | +1.3% | 501,400 |
2025/02/27 | 4,226 | 4,274 | 4,183 | 4,237 | -14 | -0.3% | 499,100 |
2025/02/26 | 4,262 | 4,290 | 4,224 | 4,251 | -20 | -0.5% | 378,000 |
2025/02/25 | 4,275 | 4,336 | 4,251 | 4,271 | -45 | -1% | 332,400 |
2025/02/21 | 4,300 | 4,360 | 4,270 | 4,316 | -39 | -0.9% | 678,200 |
2025/02/20 | 4,410 | 4,415 | 4,326 | 4,355 | -13 | -0.3% | 195,700 |
2025/02/19 | 4,381 | 4,418 | 4,368 | 4,368 | -32 | -0.7% | 164,100 |
1~
50
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム